WASHINGTON, May 30 -- Food and Drug Administration has issued a notice called: Meda AB and B. Braun Medical, Inc.; Withdrawal of Approval of Two New Drug Applications.
The notice was published in the Federal Register on May 30 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or Agency) is withdrawing approval of two new drug applications (NDAs) from two applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
For more information, contact Jennifer Scharpf, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 ...